NIFTY 50▼22,147.90
-124.60 (-0.56%)
SENSEX▼72,943.68
-456.10 (-0.62%)
NIFTY BANK▼47,484.80
-288.45 (-0.60%)
TATA MOTORS▼992.80
-6.00 (-0.60%)
INDIAN RAILWAY FINANCE CORP▲141.70
1.45 (1.03%)
SUZLON ENERGY▼40.50
-0.25 (-0.61%)
TATA POWER▼430.40
-1.20 (-0.28%)
TATA STEEL▼160.05
-0.80 (-0.50%)
YES BANK23.95
0.00 (0.00%)
INDIAN RENEWABLE ENERGY▲160.05
1.45 (0.91%)
RELIANCE INDUSTRIES▲2,931.50
1.85 (0.06%)
RELIANCE POWER▲27.35
1.30 (4.99%)
RAIL VIKAS NIGAM▲257.90
6.90 (2.75%)
HDFC BANK▲1,509.25
14.55 (0.97%)
ADANI POWER▲601.60
10.45 (1.77%)
VODAFONE IDEA▼12.95
-0.20 (-1.52%)
JIO FIN SERVICES LTD▲361.85
7.55 (2.13%)
ZOMATO▼186.45
-1.85 (-0.98%)
INDIAN RAILWAY TOURISM CORP▼1,016.45
-13.05 (-1.27%)
NHPC▲91.20
2.25 (2.53%)
STATE BANK OF INDIA▼751.70
-5.80 (-0.77%)
INDIAN OIL CORP▲169.00
2.60 (1.56%)
MRF▲1,30,333.75
889.95 (0.69%)
ITC425.90
0.00 (0.00%)
ADANI GREEN ENERGY▼1,811.65
-3.45 (-0.19%)
ADANI ENTERPRISES▼3,106.40
-41.05 (-1.30%)
JAIPRAKASH POWER VENTURES▲17.20
0.05 (0.29%)
ADANI PORT & SEZ▼1,304.35
-11.20 (-0.85%)
VENUS REMEDIES Share Price
VENUSREM
₹327.40+₹6.10 (1.90%) Past Year
₹313.10₹330.45
LH
What’s in news?
Company overview
About
Market cap
| Open₹316.00 | Close₹321.30 |
Circuit range₹385.55 - ₹257.05 | Day range₹313.10 - ₹330.45 | Year range₹188.60 - ₹430.00 |
Volume31,392 | Avg. traded₹327.05 | Revenue (12m)₹562 Cr |
VENUS REMEDIESVenus Remedies Ltd is a research-based pharmaceutical company. The Company is a global injectable manufacturer, possessing a wide product basket catering to therapeutic segments of anti-infective specially in antimicrobial resistance (AMR), oncology, skin and wound care and pain management. The Company operates in the Pharmaceutical Formulation segment. It manufactures products catering to the critical care and super specialty segments. The Company's product portfolio includes formulations such as injectables, tablets, and topical preparations. The Company offers solutions in the domains of antimicrobial resistance (AMR), oncology, skin & wound care, neurology, anticoagulants, pain management, herbal portfolio and disinfectants. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, Ventaful and Nervolize. It has three manufacturing facilities.
Read more
VENUS REMEDIES Key indicators
52 week high₹430.00 | 52 week low₹188.60 | P/E ratio15.07 |
P/B ratio0.92 | ROE6.25% | ROCE8.03% |
Dividend yield-- | Debt/Equity ratio0.08 | EPS21.67 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin13.34% | Net profit margin5.39% |
ROE6.25% | ROA4.88% |
ROCE8.03% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
VENUS REMEDIES Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Tue, Apr 16 2024 | ₹316.00 | ₹327.40 | |
Mon, Apr 15 2024 | ₹327.90 | ₹321.30 | -2.05% |
Fri, Apr 12 2024 | ₹341.70 | ₹329.30 | -3.77% |
Wed, Apr 10 2024 | ₹344.50 | ₹339.90 | -1.35% |
Tue, Apr 9 2024 | ₹349.00 | ₹342.65 | -1.85% |
Mon, Apr 8 2024 | ₹345.00 | ₹349.15 | |
Fri, Apr 5 2024 | ₹347.40 | ₹345.15 | -0.65% |
Thu, Apr 4 2024 | ₹353.00 | ₹348.05 | -1.42% |
Events
No data available at the moment